This announcement is a separate document:
浙江华康药业股份有限公司向不特定对象发行可转换公司债券第二次临时受托管理事务报告（2024年度）
Zhejiang Huakang Pharmaceutical Co., Ltd. Second Interim Management Report on Issuance of Convertible Corporate Bonds to Unspecified Targets (2024)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.